Vidgastech: Pioneering Excellence in Palbociclib Intermediates Vidgastech is at the forefront of high-quality Palbociclib intermediate manufacturing in India, catering to the evolving needs of the pharmaceutical industry. With a strong commitment to innovation, precision, and regulatory compliance, we ensure the production of high-purity intermediates that support the synthesis of Palbociclib, a critical CDK4/6 inhibitor used in advanced breast cancer treatment. Our state-of-the-art facilities and stringent quality control measures guarantee reliability and efficiency, making us a trusted partner for pharmaceutical companies worldwide. At Vidgastech, we prioritize sustainable manufacturing, cost-effective solutions, and global pharmaceutical standards to enhance the accessibility of life-saving drugs. Our dedicated R&D team and advanced production technologies enable us to deliver consistent and superior-quality Palbociclib intermediates that empower oncology research and treatment. As a leading player in the pharmaceutical sector, we continue to drive innovation, ensuring that the future of cancer therapeutics remains strong, effective, and accessible.